The Oncology Innovation Interchange brand, founded in 2006 (United States), from 496 sister brands and 17478 competing brands. The Oncology Innovation Interchange brand is owned by BRISTOL-MYERS SQUIBB COMPANY, a company listed in New York. Oncology Innovation Interchange belongs to the Drug Manufacturers business sector.